Medmira (TSE:MIR) has released an update. MedMira Inc. has reported progress in expanding its market presence and securing regulatory approvals. The company received FDA approval for its HIV test and
Medmira (TSE:MIR) has released an update. MedMira Inc. has reported progress in expanding its market presence and securing regulatory approvals. The company received FDA approval for its HIV test and
Medmira (TSE:MIR) has released an update. MedMira Inc. has announced the strategic appointment of Nicole Crenshaw as Vice President of Commercial Operations to strengthen its leadership team and push forward
Medmira (TSE:MIR) has released an update. MedMira Inc. has announced the launch of clinical trials for its innovative Multiplo Complete Syphilis Antibody Test in Canada, aiming to offer a rapid
Medmira (TSE:MIR) has released an update. Medmira Inc. has successfully launched its FDA-approved Reveal G4 Rapid HIV 1/2 test, expanded its distribution network, and secured significant new clients in Q3
Medmira Inc (TSE:MIR) has released an update. Medmira Inc. has strengthened its commercial team with the appointment of Rene Bell as the new Vice President of Business Development, bringing over